An 11-year old male hemodialysis patient developed a firm, painless mass of insidious onset on the right nasal bridge that gradually increased in size involving the left nasal bridge and the left mandible over a 2-year duration, resulting in difficulty chewing (Fig. 1) .
He had an underlying diagnosis of congenital anomalies of the kidney and urinary tract (CAKUT), with posterior urethral valve and absent left kidney. At 4 years of age, he was commenced on renal replacement therapy in the form of peritoneal dialysis (PD). This was complicated by recurrent peritonitis, and catheter blockage and displacement, which required a change to hemodialysis modality at 4.5 years of age, undergoing three sessions per week (12 h/week). He had severe growth failure (height standard deviation score − 4.3) and commenced recombinant human growth hormone at 2 years of age. Growth hormone was continued for 8 years, but he remained below the third percentile. He developed chronic bone pain, with slowly progressive long-bone deformities and became confined to a wheelchair at 6 years of age. Besides hemodialysis, he was treated with bicarbonate to control his acid-base balance, along with phosphate binders (sevelamer), 1-alpha hydroxylated vitamin D 3 (orally and intravenously), and calcimimetics (Cinacalcet), which was started at 10 years of age, resulting in cessation of tumor growth without regression in size. Table 1 is a summary of his bone profile and creatinine across the years.
At the date of writing this quiz, the child was receiving regular hemodialysis sessions, with no apparent improvement in biochemical markers or tumor regression. 
